| Lactose (India) Ltd | 136 Cr. | 108 | 247/84.3 | 31.0 | 46.7 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.52 Cr. | 1.84 | 4.33/1.82 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,937 Cr. | 453 | 479/192 | 102 | 24.3 | 0.15 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 33.4 Cr. | 45.1 | 92.2/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 37.3 Cr. | 25.4 | 29.1/17.0 | 38.8 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 60.8 Cr. | 80.7 | 134/78.9 | 16.0 | 57.6 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 51,539 Cr. | 1,830 | 2,286/1,275 | 38.7 | 314 | 0.14 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 344 Cr. | 15.1 | 21.0/10.8 | 20.9 | 8.21 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.2/9.25 | 88.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 769 Cr. | 1,629 | 1,785/635 | 26.6 | 334 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 118 Cr. | 23.7 | 32.0/15.0 | 32.3 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 816 Cr. | 277 | 449/219 | 7.81 | 123 | 0.90 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | 37.2 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 10.8 Cr. | 4.33 | 9.28/2.11 | 6.12 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 381 Cr. | 392 | 477/112 | 61.3 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,960 Cr. | 1,143 | 1,565/1,038 | 48.4 | 396 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 59.3 Cr. | 0.29 | 1.24/0.26 | 3.90 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 47.8 Cr. | 19.9 | 26.3/6.40 | 49.3 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 9.85 Cr. | 9.75 | 17.2/9.01 | | 22.6 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 177 Cr. | 497 | 889/443 | 9.61 | 563 | 0.30 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 77.8 Cr. | 77.8 | 77.8/26.1 | 199 | 34.1 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 15,005 Cr. | 1,439 | 2,452/1,345 | 42.0 | 173 | 0.74 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 18.2 Cr. | 39.8 | 88.7/37.6 | 39.5 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 18.4 Cr. | 7.37 | 7.66/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 17.3 Cr. | 116 | 154/63.0 | | 87.6 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 41.2 Cr. | 75.3 | 75.3/9.41 | 458 | 1.02 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 30.2 Cr. | 40.0 | 80.0/0.00 | 42.5 | 39.7 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.33 Cr. | 21.1 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 10,209 Cr. | 590 | 1,028/492 | 29.0 | 72.4 | 0.20 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 87.3 Cr. | 20.2 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 12.1 Cr. | 24.0 | 43.7/17.4 | 52.8 | 18.7 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 92,256 Cr. | 2,237 | 3,055/2,115 | 55.4 | 376 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 269 Cr. | 467 | 524/241 | 28.2 | 119 | 0.96 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 42.4 Cr. | 29.6 | 62.6/26.8 | 38.2 | 17.7 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 67,715 Cr. | 1,155 | 1,365/994 | 19.8 | 598 | 0.35 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 112 Cr. | 179 | 303/170 | 162 | 69.0 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 817 Cr. | 81.5 | 123/74.0 | 21.1 | 32.6 | 1.84 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 40.9 Cr. | 31.3 | 50.0/21.0 | | 51.2 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 14,422 Cr. | 1,764 | 1,868/919 | 64.4 | 160 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.29 Cr. | 0.65 | 1.45/0.55 | 107 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 246 Cr. | 32.1 | 68.0/30.0 | 13.1 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 8.28 Cr. | 14.2 | 25.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 122 Cr. | 5.20 | 6.57/2.82 | 285 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 62,663 Cr. | 29,505 | 37,000/25,260 | 41.5 | 1,888 | 1.61 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,951 Cr. | 766 | 972/550 | 29.0 | 226 | 0.65 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 280 Cr. | 99.0 | 100/31.3 | 67.3 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,643 Cr. | 1,531 | 1,628/535 | | 104 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 22,100 Cr. | 1,361 | 1,870/1,110 | 403 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 850 Cr. | 243 | 330/154 | 19.8 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 623 Cr. | 469 | 568/270 | 13.3 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,250 Cr. | 462 | 950/455 | 26.0 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,594 Cr. | 1,136 | 1,595/991 | 22.6 | 768 | 0.88 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,29,214 Cr. | 3,818 | 3,835/2,886 | 59.6 | 250 | 0.84 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 1,106 Cr. | 120 | 317/98.0 | | 43.7 | 0.42 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,512 Cr. | 16.1 | 24.0/14.1 | 26.6 | 3.62 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 26,973 Cr. | 705 | 1,360/700 | 76.7 | 66.6 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 4,264 Cr. | 187 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,07,034 Cr. | 1,698 | 1,910/1,547 | 35.3 | 324 | 0.94 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,457 Cr. | 551 | 886/441 | 383 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,747 Cr. | 293 | 329/175 | 33.9 | 81.2 | 0.14 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 359 Cr. | 1,198 | 1,680/956 | 19.2 | 683 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 7,508 Cr. | 383 | 502/265 | 58.4 | 121 | 0.13 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 5,659 Cr. | 224 | 230/111 | 187 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 10,579 Cr. | 4,598 | 6,718/4,146 | 28.6 | 340 | 2.54 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,887 Cr. | 2,345 | 2,725/1,772 | 34.9 | 335 | 0.85 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,869 Cr. | 5,941 | 6,739/4,904 | 32.2 | 373 | 2.10 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 171 Cr. | 48.4 | 87.5/42.0 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 23,528 Cr. | 5,140 | 5,993/3,701 | 34.8 | 922 | 0.68 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 121 Cr. | 98.1 | 348/81.0 | 8.52 | 80.4 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,487 Cr. | 406 | 582/281 | | 136 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 4,287 Cr. | 844 | 1,998/604 | 50.3 | 250 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 23,259 Cr. | 18,113 | 19,748/10,060 | 119 | 1,263 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 335 Cr. | 14.9 | 44.9/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 14,295 Cr. | 799 | 1,505/660 | 8.42 | 425 | 0.75 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,546 Cr. | 46.5 | 91.7/41.7 | 27.5 | 21.1 | 0.43 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,483 Cr. | 187 | 359/162 | 24.2 | 54.4 | 0.43 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 97.2 Cr. | 61.8 | 130/60.4 | | 93.9 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 335 Cr. | 93.6 | 177/90.2 | 44.7 | 29.0 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 90,919 Cr. | 1,990 | 2,403/1,774 | 21.0 | 430 | 0.60 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,039 Cr. | 522 | 980/499 | 12.0 | 335 | 0.34 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 54,020 Cr. | 1,001 | 1,004/474 | 79.1 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 887 Cr. | 854 | 1,235/596 | 20.4 | 256 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 145 Cr. | 67.2 | 129/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 779 Cr. | 161 | 312/154 | 22.3 | 107 | 1.86 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 641 Cr. | 367 | 500/265 | 22.9 | 116 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 18,207 Cr. | 1,138 | 1,265/802 | 36.6 | 414 | 0.44 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 28,416 Cr. | 1,813 | 1,952/1,303 | 41.5 | 221 | 0.85 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,420 Cr. | 213 | 328/193 | 32.5 | 38.0 | 1.17 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 34,029 Cr. | 1,345 | 1,758/1,168 | 38.0 | 274 | 0.30 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,620 Cr. | 89.2 | 127/57.5 | 24.9 | 57.5 | 0.90 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 765 Cr. | 104 | 124/67.2 | 34.7 | 194 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,453 Cr. | 266 | 355/190 | | 106 | 0.08 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,854 Cr. | 232 | 465/229 | 45.1 | 102 | 0.60 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,379 Cr. | 1,617 | 2,770/1,243 | 36.7 | 369 | 0.43 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,178 Cr. | 318 | 498/285 | 52.0 | 60.0 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,346 Cr. | 550 | 628/412 | 28.0 | 153 | 0.27 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 51,539 Cr. | 1,830 | 2,286/1,275 | 38.7 | 314 | 0.14 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 42,982 Cr. | 2,540 | 3,516/1,921 | 45.1 | 101 | 1.65 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 31,030 Cr. | 1,881 | 2,131/1,200 | 26.8 | 610 | 0.96 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,739 Cr. | 414 | 530/359 | 29.9 | 149 | 1.21 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 21,745 Cr. | 1,592 | 1,910/1,097 | 56.2 | 210 | 0.46 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,00,053 Cr. | 1,199 | 1,406/1,020 | 17.3 | 432 | 0.67 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,899 Cr. | 249 | 322/177 | 26.1 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,22,196 Cr. | 1,512 | 1,673/1,310 | 22.5 | 408 | 0.86 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,777 Cr. | 1,943 | 2,641/1,551 | 25.1 | 416 | 0.31 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 302 Cr. | 103 | 203/95.6 | 149 | 33.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,561 Cr. | 148 | 191/105 | 14.2 | 99.7 | 0.34 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 62.9 Cr. | 38.8 | 72.0/37.7 | 22.5 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 51,126 Cr. | 382 | 406/291 | 141 | 180 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,706 Cr. | 1,690 | 2,215/1,430 | 37.7 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 129 Cr. | 80.9 | 141/76.3 | 18.0 | 48.6 | 1.48 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 403 Cr. | 183 | 195/67.8 | 40.0 | 35.8 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,704 Cr. | 9,083 | 10,691/6,220 | 98.2 | 320 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,034 Cr. | 704 | 843/544 | 35.9 | 118 | 0.65 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 173 Cr. | 82.8 | 137/79.7 | 6.56 | 86.4 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 67,838 Cr. | 5,680 | 5,751/4,492 | 29.8 | 1,002 | 0.79 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 18,220 Cr. | 927 | 1,124/725 | 28.7 | 271 | 1.19 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 486 Cr. | 851 | 1,540/763 | 77.3 | 688 | 0.59 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 31,575 Cr. | 2,529 | 3,116/2,022 | 32.4 | 345 | 1.11 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,475 Cr. | 310 | 469/258 | 25.4 | 127 | 1.68 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 4,788 Cr. | 520 | 575/312 | 25.1 | 146 | 0.19 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 19,998.92 Cr | 1,191.15 | | 55.95 | 199.13 | 0.34% | 16.24% | 14.95% | 6.10 |